Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Literature
1.
Wynne-Jones G, Mallen CD, Mottram S, Main CJ, Dunn KM (2009) The identification of U.K. sickness certification rates, standardised for age and sex. Br J Gen Pract 58:510–516CrossRef
2.
Waddell G, Aylward M (2005) The scientific and conceptual basis of incapacity benefits. TSO, London
3.
Burdorf A, Post W, Bruggeling T (1996) Reliability of a questionnaire on sickness absence with specific attention to absence due to back pain and respiratory complaints. Occup Environ Med 53:58–62CrossRefPubMed
4.
Porcheret M, Hughes R, Evans D, Jordan K, Whitehurst T, Ogden H (2004) Data quality of general practice electronic health records: the impact of a program of assessments, feedback, and training. J Am Med Inform Assoc 11:78–86CrossRefPubMed
5.
Shiels C, Gabbay M (2006) The influence of GP and patient interaction on the duration of certified sickness absence. Fam Pract 23:246–252CrossRefPubMed
Metadata
Title
Sickness certification for musculoskeletal conditions
Authors
Gwenllian Wynne-Jones
Christian D. Mallen
Kate M. Dunn
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1400-z

Other articles of this Issue 5/2010

Clinical Rheumatology 5/2010 Go to the issue

Original Article

The relation of serum vascular endothelial growth factor level with disease duration and activity in patients with rheumatoid arthritis

Case Report

Successful treatment of severe nodular scleritis with adalimumab

Brief Report

Serum hyaluronic acid levels do not explain morning stiffness in patients with fibromyalgia

Brief Report

Connective tissue diseases after heavy exposure to silica: a report of nine cases in stonemasons

Original Article

Comparison between clinical and ultrasonographic assessment in patients with erosive osteoarthritis of the hands

Case Report

Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler’s syndrome: a case report and literature review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits